It was observed that persistent exposure to an anti PD-1 antibody upregulated TIM-3 expression in a tumor-bearing lung in mouse models, which supports the idea that a TIM-3/PD-1 blockade may have great therapeutic potential [110,111,112]. The gene discussed is HAVCR2; the disease is neoplasm.